The Journal of Korean Medicine (대한한의학회지)
- Volume 27 Issue 4
- /
- Pages.62-73
- /
- 2006
- /
- 1010-0695(pISSN)
- /
- 2288-3339(eISSN)
Effects of Saenghyul-dan (SHD) on the Myelosuppression Induced by 5-Fluorouracil
- Lee, Gi-Joon (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) ;
- Son, Chang-Gue (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) ;
- Lee, Yeon-Weol (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) ;
- Lee, Nam-Heon (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) ;
- Yun, Dam-Hee (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) ;
- Yoo, Hwa-Seung (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) ;
- Cho, Chong-Kwan (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) ;
- Cho, Jung-Hyo (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University)
- Published : 2006.12.30
Abstract
Objective : This study aimed to investigate the effect of SHD on myelosuppression using an animal model for therapeutic evidence supporting clinical positive results. Methods : After determining the optimal concentration of 5-FU as 300 mg/kg for developing the mouse model, ICR mice or BALB/c mice were administered with SHD, and several blood parameters, including hematopoietic cytokines, colony forming activity and histological findings, were examined to evaluate the effects. Results : SHD restored the WBC and hemoglobin, and showed effects on maintaining body weight, producing GM-CSF and IL-3 and stem cell colony forming activity in accordance with histological relative entirety on bone marrow. Conclusion : SHD is an herbal drug having therapeutic effects on myelosuppression. Thus, it could be prescribed to cancer patients undergoing chemo-therapies or radio-therapies in the process of cancer treatment.